title: Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection.
authors.forename: Edgar
authors.initials: E
authors.lastname: Bautista
authors.forename: Tawee
authors.initials: T
authors.lastname: Chotpitayasunondh
authors.forename: Zhancheng
authors.initials: Z
authors.lastname: Gao
authors.forename: Scott A
authors.initials: SA
authors.lastname: Harper
authors.forename: Michael
authors.initials: M
authors.lastname: Shaw
authors.forename: Timothy M
authors.initials: TM
authors.lastname: Uyeki
authors.forename: Sherif R
authors.initials: SR
authors.lastname: Zaki
authors.forename: Frederick G
authors.initials: FG
authors.lastname: Hayden
authors.forename: David S
authors.initials: DS
authors.lastname: Hui
authors.forename: Joel D
authors.initials: JD
authors.lastname: Kettner
authors.forename: Anand
authors.initials: A
authors.lastname: Kumar
authors.forename: Matthew
authors.initials: M
authors.lastname: Lim
authors.forename: Nahoko
authors.initials: N
authors.lastname: Shindo
authors.forename: Charles
authors.initials: C
authors.lastname: Penn
authors.forename: Karl G
authors.initials: KG
authors.lastname: Nicholson
mesh_terms: D000956:Antigens, Viral / Q000032:analysis; D000998:Antiviral Agents / Q000627:therapeutic use; D004196:Disease Outbreaks; D024882:Drug Resistance, Viral; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000302:isolation & purification / Q000472:pathogenicity; D007251:Influenza, Human / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000276:immunology; D008168:Lung / Q000276:immunology / Q000473:pathology; D053139:Oseltamivir / Q000627:therapeutic use; D012367:RNA, Viral / Q000032:analysis; D012307:Risk Factors; D012720:Severity of Illness Index
chemical_list: D000956:Antigens, Viral; D000998:Antiviral Agents; D012367:RNA, Viral; D053139:Oseltamivir